先天免疫系统
细胞疗法
巨噬细胞
免疫学
医学
疾病
免疫系统
细胞
移植
肝移植
免疫
肝病
生物
病理
体外
内科学
生物化学
遗传学
作者
Philip J. Starkey Lewis,Francesca Moroni,Stuart J. Forbes
出处
期刊:Seminars in Liver Disease
[Georg Thieme Verlag KG]
日期:2019-06-26
卷期号:39 (04): 442-451
被引量:29
标识
DOI:10.1055/s-0039-1688502
摘要
Abstract Liver failure arising from acute and chronic liver disease is an unmet clinical need that urgently requires novel therapeutic options in addition to orthotopic liver transplantation. Cell therapies offer new strategies to recover liver function through the reconstitution of healthy parenchyma and resolution of tissue pathology. Macrophages are professional phagocytes that comprise a key part of the innate immune system providing an important defense mechanism against invading pathogens. Macrophages are an inherently diverse cell type with respect to ontogeny, tissue distribution, phenotype, and function. The ability of macrophages to afford innate immunity, efficiently scavenge apoptotic/necrotic cells, and modulate local tissue microenvironment makes them an attractive cell therapy candidate for various diseases. This review aims to outline the rationale and utility of macrophages to serve as a potential cell therapy for liver disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI